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The Ebola Epidemic
A Global Health Emergency
On August 8, the World Health Organization (WHO)
Director-General Margaret Chan declared the West Africa
Ebola crisis a “public health emergency of international
concern,”1 triggering powers under the 2005 Interna-
tional Health Regulations (IHR). The IHR requires coun-
tries to develop national preparedness capacities, in-
cluding the duty to report internationally significant
events, conduct surveillance, and exercise public health
powers, while balancing human rights and interna-
tional trade. Until last year, the director-general had
declared only one such emergency—influenza AH1N1 (in
2009). Earlier this year, she declared poliomyelitis a
public health emergency of international concern and
now again for Ebola, signaling perhaps a new era of po-
tential WHO leadership in global health security.
The West African Ebola Epidemic
Ebola virus disease (EVD) has 3 species of human sig-
nificance: Zaire, Sudan, and Bundibugyo. The West Africa
outbreak is from a new strain of the Zaire species,2 with
a reported case-fatality rate of 55%. Infection can cause
fever, vomiting, diarrhea, and generalized bleeding as
well as death.
FruitbatslikelycarryEbolavirus,withhumansinfected
by close contact with infected body fluids and “bushmeat”
of primates, forest antelope, wild pigs, and bats. Human-
to-human transmission occurs only by close contact with
infectedbodyfluids. Importantly,noairbornetransmission
betweenhumanshasbeendemonstrated.EarlyEVDsymp-
toms are similar to those of malaria and typhoid fever—
as well as endemic hemorrhagic fevers such as Lassa—
rendering symptomatic differential diagnosis difficult.
Before the current outbreak began in December
2013, West Africa had no recorded Ebola deaths. Yet this
outbreak is the largest, with the crisis worsening. As of
August 8, WHO reported 1779 Ebola cases, with 961
deaths.3 Cases were first reported in Guinea on March
23, followed by Liberia, Sierra Leone, and Nigeria (due
to an infected airline passenger from Liberia). Of great-
est concern is the potential urban spread, including capi-
tal cities. Previously Ebola was concentrated in rural
areas, where the public health response was suffi-
ciently rapid to prevent spread to populated cities.
Vaccines and Treatment: Ethical Dilemmas
Since 1976 more than 15 Ebola outbreaks have erupted
in sub-Saharan Africa, yet therapeutic options remain un-
developed. There are no licensed vaccines or specific an-
tiviral or immune-mediated treatments for ill patients or
for postexposure prophylaxis. The US National Insti-
tutes of Health is supporting the first phase 1 clinical trial
of a new prototype experimental vaccine expected to
begin in September 2014.
Fueling disquiet about global justice, 2 US aid workers
infected in Liberia were treated with an experimental
anti-Ebola antibody prior to being transported to Atlanta.4
This serum had been previously used only in nonhuman
primates.5 Even though the serum’s safety and efficacy re-
main unknown, it sparked an international controversy.
Should US workers receive a drug in extremely scarce sup-
ply when Africans are affected in far greater numbers?
Balanced against this sense of injustice is the ethical con-
cern of administering an experimental drug to African pa-
tientsthathasnotundergoneanysafetytestinginhumans.
On August 11, WHO convened an expert committee
to assess the bioethical implications of withholding or pro-
viding early access to experimental treatments.6 If a scarce
treatment offers benefits to patients, the ethical question
is who should have priority access? Society, for example,
owes a duty to health workers who place themselves at
heightened risk. Other ethical considerations could grant
priority to patients most likely to benefit, as well as target-
ing the drug to prevent spread in hospitals or the commu-
nity. Moreover, who should decide whether an experimen-
tal treatment should be administered? Liberian officials
apparently did not approve the use of an investigational
drug administered in their territory.7 National leaders also
would need to be part of future decision making processes
for allocating scarce vaccines and medications.
Public Health Countermeasures
Sierra Leone’s president captured the state of crisis: “The
very essence of our nation is at stake.”8 Without effec-
tive vaccines or treatments, West African governments
have declared public health emergencies, invoking ex-
traordinary powers—a divisive trade-off between popu-
lation health and human rights. The following classic pub-
lic health measures are standard responses to EVD but
are supported by variable levels of evidence.
Isolation and Quarantine. Affected states have invoked
multiple forms of quarantine, ranging from stay-at-home
days for “reflection, education, and prayers” to guarded
home confinement. The military has been deployed for
house-to-house searches, traveler checkpoints, and cor-
don sanitaire (a guarded line preventing anyone from
leaving)—sometimes separating people and regions of the
country. Yet states have exhibited lax enforcement, with
the inability to police an evolving crisis. Given EVD’s in-
cubation period, quarantine must last up to 21 days—a task
requiring intensive monitoring, enforcement, and deliv-
ery of essential services such as food and health care.
Social Distancing. Governments have invoked social dis-
tancing, such as school closures and bans on public gath-
erings, including sporting, shopping, and entertain-
ment. In some areas, fear has produced an eerie quiet
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in usually bustling neighborhoods, while in other areas social life has
continued unabated.
Risk Communication and Burial. Public education has been incom-
plete, with governments occasionally impeding news coverage and
accurate risk communication.9 Ministries of health have ordered
mandatory reporting and required cremation of bodies. Yet tradi-
tional burial services often continue, with loved ones in close con-
tact with the deceased, posing transmission risks.
Travel Restrictions. Porous borders place West Africa in jeopardy, but
airline travel could propel Ebola’s international spread, as occurred
in Nigeria. Nigeria is screening all arriving air passengers, while sev-
eral air carriers temporarily suspended flights to the region. The US
Centers for Disease Control and Prevention (CDC) issued a level 3
travel warning to the region, reserved for the most serious threats.
Health Care Settings. Without trained staff, isolation units, per-
sonal protective equipment, and strict infection control, hospitals
have become “amplification points” for spread of EVD, placing health
workers at significant risk; approximately 140 African health care
workers have been infected, with 80 deaths.10 The high risk in-
curred by workers, often with inadequate salaries, has com-
pounded a severe human resource shortage. There are numerous
ethical dilemmas, such as whether health professionals have a duty
to report to work without adequate personal protective equip-
ment. The United States is considering medical evacuation of in-
fected aid workers, while the CDC will send additional workers to the
region. Beyond health workers, patients fearing EVD have shunned
hospitals, remaining in the community without adequate treat-
ment. Affected states rank lowest in global development, with frag-
ile health systems and lacking the capacity and expertise to contain
the epidemic and treat those infected.
Global Governance
The West African Ebola crisis is unique given the virulence, inten-
sive community and health facility transmission patterns, and weak
health systems. The WHO director-general’s declaration of a public
health emergency of international concern underscores the ur-
gency of a coordinated international response and the imperative
of raising the capacity of low-income states. The WHO declaration
triggered temporary recommendations directed to affected states,
bordering states, and the international community.
Affected States. The WHO director-general asked states with ac-
tive Ebola transmission to declare a national emergency, activate di-
saster management plans, and establish emergency operation cen-
ters. Emergency funding should build core capacities including
infection prevention and control. The director-general urged mo-
bilization of health workers, with full remuneration, personal pro-
tective equipment, and worker safety assurances. Traditional lead-
ers and healers should be fully engaged in risk communication.
All confirmed cases should be isolated and treated, while exposed
individuals should be monitored daily, with restricted travel within
the 21-day incubation period. However, to protect freedom of move-
ment, the director-general did not recommend travel bans but ad-
vised exit screening at international airports, seaports, and land-
crossings. Individuals with EVD-like illness should not be allowed to
travel except for medical evacuation.
Land-Border States. Land-border states should conduct rigorous sur-
veillance to quickly identify clusters of unexplained fevers or deaths,
with qualified laboratories, rapid-response teams for contact inves-
tigations, and case management.
The International Community. The director-general cautioned against
international travel or trade restrictions, except for EVD cases and
contacts. All states should implement risk communication and labo-
ratory diagnostics and prepare for medical evacuations. Interna-
tional capacity building for low-income states was conspicuously ab-
sent in the recommendations, even though it is arguably the most
effective and humane way to contain the outbreak.
Years of civil unrest and weak development have left West Africa
with fragile health systems as it faces a crisis. Although the director-
general urged international solidarity, global governance once again
was weakened from a lack of capacity in developing countries. A sus-
tainable solution to EVD, and other emerging threats, requires bind-
ing commitments for funding and technical assistance to build na-
tional preparedness capabilities, including surveillance, laboratories,
health systems, and rapid response.
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